HiPoint Reperfusion System
Acute Ischemic Stroke (Large Vessel Occlusion)
Pivotal TrialActive
Key Facts
Indication
Acute Ischemic Stroke (Large Vessel Occlusion)
Phase
Pivotal Trial
Status
Active
Company
About Route 92 Medical
Route 92 Medical is a neurovascular medical device innovator tackling key limitations in endovascular stroke therapy, such as difficult vessel access and procedural inefficiency. Its flagship technology platform, centered on the Tenzing delivery catheter and FreeClimb reperfusion systems, is designed to navigate tortuous anatomy more reliably and enable faster, more effective clot removal. The company is in the commercial stage for its initial products while also conducting a pivotal trial (SUMMIT MAX) for its next-generation HiPoint Reperfusion System, positioning it in the high-growth stroke intervention market.
View full company profileTherapeutic Areas
Other Acute Ischemic Stroke (Large Vessel Occlusion) Drugs
| Drug | Company | Phase |
|---|---|---|
| FreeClimb Catheter Systems (54, 70, 88) | Route 92 Medical | Approved |
| Lead Ischemic Stroke Program | RapidPulse | Pivotal |
| NeVa / NeVa VS | Vesalio | Commercial |
| Millipede 088 Aspiration Catheter | Perfuze | Pivotal Trial (IDE) |